MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Association Between Anticholinergic Burden, MCI, and Cholinergic Denervation

    R. Paalanen, S. Roytman, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To characterize the relationship between anticholinergic burden (ACB), mild cognitive impairment (MCI), and its underlying cholinergic pathology. Background: MCI is a common phenomenon in…
  • 2023 International Congress

    Foslevodopa/foscarbidopa in patients with advanced Parkinson’s disease: subgroup analyses from a phase 3, randomized study

    M. Soileau, N. Fisseha, A. Jeong, T. Kimber, K. Klos, W. Robieson, S. Talapala, E. Vaou, H. Zheng, M. Facheris, R. Hauser (Georgetown, USA)

    Objective: Present the efficacy and safety of 24-hour/day continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) across pre-specified subgroups (age, sex, body mass index [BMI], race,…
  • 2023 International Congress

    Developement and acceptability testing of a patient decision aid on levodopa/carbidopa intestinal gel.

    C-C. Cayer, IBB. Beaulieu-Boire, A-T. Tanguay (Sherbrooke, Canada)

    Objective: To develop a patient decision aid on levodopa/carbidopa intestinal gel (LCIG) and to test its acceptability. Background: : Advanced Parkinson’s disease (PD) is characterized…
  • 2023 International Congress

    Rest Tremor in Parkinson’s Disease Is Associated with Increased Ipsilateral DAT Binding

    K. Niemi, J. Sunikka, V. Kaasinen, J. Joutsa (Turku, Finland)

    Objective: To investigate the connection between striatal dopamine transporter binding and cardinal motor symptoms of Parkinson’s disease. Background: The three cardinal motor symptoms of Parkinson’s…
  • 2023 International Congress

    The Short Duration Response and Long Duration Response to L-Dopa are Needed to Restore Vigor-Motivation Coupling in Parkinson Disease

    J. Brissenden, T. Scerbak, R. Albin, T. Lee (Ann Arbor, USA)

    Objective: To assess the relationship between the Short Duration Response (SDR) and Long Duration Response (LDR) to L-Dopa therapy in Parkinson disease (PD) and restoration…
  • 2023 International Congress

    Comparative study of Non-Motor Symptoms and it’s correlation with Quality of Life in Parkinson’s disease and Atypical Parkinsonism

    D. Joshi, A. Kumar, M. Tapadia (varanasi, India)

    Objective: The present study aimed to evaluate and compare the non-motor symptoms and their correlation with quality of life in patients with PD and AP.…
  • 2023 International Congress

    Correlation between oculometric measures, disease severity, and clinical assessment in patients with Parkinson’s disease

    J. Reiner, L. Franken, E. Raveh, I. Rosset, R. Kreitman, E. Ben-Ami, R. Djaldetti (Petah Tikva, Israel)

    Objective: To evaluate the correlation between oculometric measures (OMs), disease severity, and clinical assessment in a cohort of patients with Parkinson’s disease (PD). Background: Oculometric…
  • 2023 International Congress

    Is it safe to switch from constant voltage to constant current with a mixed Internal Pulse Generator in deep brain stimulation

    G. Ozturk Ozluk (Istanbul, Turkey)

    Objective: Deep brain stimulation (DBS) is an efficient treatment modality for Parkinson's Disease (PD), essential tremor and dystonia. Differing from the Constant Voltage-(CV)-DBS devices, Constant…
  • 2023 International Congress

    Delta(0.5-2Hz) Spectral Power reduction in the frontal region in NREM Sleep are Associated with dyskinesia in Parkinson’s Disease

    CJ. Mao, YM. Wang, F. Wang, CK. Zhong, S. Zhuang, XY. Cheng, JY. Liu, CF. Liu (Suzhou, China)

    Objective: Our study aimed to establish the objective physiological indicators assessed by polysomnography(PSG) that are associated with dyskinesia in PD patients.Our study aimed to establish…
  • 2023 International Congress

    GBA haplotypes and age at onset of Parkinson’s disease in the Asian population

    C. Li, R. Ou, Y. Hou, Q. Wei, L. Zhang, K. Liu, J. Lin, X. Chen, W. Song, B. Zhao, Y. Wu, H. Shang (Chengdu, China)

    Objective: To explore the involvement of GBA haplotypes in age at onset of Parkinson's disease in the Asian population. Background: GBA is an important risk…
  • « Previous Page
  • 1
  • …
  • 320
  • 321
  • 322
  • 323
  • 324
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley